Manufacturer of Controlled Substances Notice of Registration, 77062-77063 [E6-21879]
Download as PDF
<![CDATA[
77062
Federal Register / Vol. 71, No. 246 / Friday, December 22, 2006 / Notices
activities. The notifications were filed
for the purpose of extending the Act’s
provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, TCIA recently finalized
and adopted four standards: BSR A300
Part 5 Management of Trees and
Shrubs—Standard Practices
(Management of Trees and Shrubs
During Site Planning, Site Development,
and Construction); BSR A300 Part 6
Transplanting; PINS A300 Part 7
Integrated Vegetation Management; and
TCIA Accreditation Council Standards
for Accreditation Draft 5 Version 2.
On September 8, 2004, TCIA filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on October 4, 2004 (69 FR 59271).
Patricia A. Brink,
Deputy Director of Operations, Antitrust
Division.
[FR Doc. 06–9833 Filed 12–22–06; 8:45 am]
BILLING CODE 4410–11–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances Notice of Registration
By Notice dated August 15, 2006, and
published in the Federal Register on
August 22, 2006, (71 FR 48944), Aldrich
Chemical Company, Inc., DBA Isotec,
3858 Benner Road, Miamisburg, Ohio
45342–4304, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
schedule I and II:
jlentini on PROD1PC65 with NOTICES
Drug
Schedule
Cathinone (1235) ..........................
Methcathinone (1237) ..................
N-Ethylamphetamine (1475) ........
N,N-Dimethylamphetamine (1480)
Aminorex (1585) ...........................
Gamma
hydroxybutyric
acid
(2010).
Methaqualone (2565) ...................
Ibogaine (7260) ............................
Lysergic acid dethylamide (7315)
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4-Methylenedioxy-methamphetamine (7405).
4-Methoxyamphetamine (7411) ...
VerDate Aug<31>2005
17:45 Dec 21, 2006
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Jkt 211001
Drug
Schedule
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
N-Ethyl-1-phenylcyclohexylamine
(7455).
Dihydromorphine (9145) ...............
Normorphine (9313) .....................
Acetylmethadol (9601) .................
Alphacetylmethadol Except LevoAlphacetylmethadol (9603).
Normethadone (9635) ..................
Norpipanone (9636) .....................
3-Methylfentanyl (9813) ................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
1-Phenylcyclohexylamine (7460)
Phencyclidine (7471) ....................
Phenylacetone (8501) ..................
1Piperidinocyclohexanecarbonitrile (8603).
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Benzoylecgonine (9180) ...............
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Isomethadone (9226) ...................
Meperidine (9230) ........................
Meperidine intermediate-A (9232)
Merperidine intermediate-B (9233)
Methadone (9250) ........................
Methadone intermediate (9254) ...
Dextropropoxyphene, bulk, (nondosage forms) (9273).
Morphine (9300) ...........................
Normorphine (9313) .....................
Thebaine (9333) ...........................
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ...................
Fentanyl (9801) ............................
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances to produce isotope labeled
standards for drug testing and analysis.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Aldrich Chemical Company, Inc. to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Aldrich Chemical
Company, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
PO 00000
Frm 00103
Fmt 4703
Sfmt 4703
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: December 14, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–21880 Filed 12–21–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances Notice of Registration
By Notice dated August 15, 2006, and
published in the Federal Register on
August 22, 2006, (71 FR 48944–48945),
American Radiolabeled Chemicals, Inc.,
101 Arc Drive, St. Louis, Missouri
63146, made application by renewal and
by correspondence dated June 2, 2006,
to the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in schedule
I and II:
Drug
Gamma
hydroxybutyric
acid
(2010).
Ibogaine (7260) ............................
Lysergic acid diethylamide (7315)
Tetrahydrocannabinols (7370) .....
Dimethyltryptamine (7435) ...........
Dihydromorphine (9145) ...............
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Amobarbital (2125) .......................
Phencyclidine (7471) ....................
Phenylacetone (8501) ..................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Ecgonine (9180) ...........................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Metazocine (9240) ........................
Morphine (9300) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Fentanyl (9801) ............................
Schedule
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances as radiolabeled compounds
for biochemical research.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
American Radiolabeled Chemicals, Inc.
to manufacture the listed basic classes
of controlled substances is consistent
E:\FR\FM\22DEN1.SGM
22DEN1
77063
Federal Register / Vol. 71, No. 246 / Friday, December 22, 2006 / Notices
with the public interest at this time.
DEA has investigated American
Radiolabeled Chemicals, Inc. to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: December 14, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–21879 Filed 12–21–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated July 26, 2006, and
published in the Federal Register on
August 14, 2006, (71 FR 46514–46515),
Applied Science Labs, Division of
Alltech Associates Inc., 2701 Carolean
Industrial Drive, State College,
Pennsylvania 16801, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
schedules I and II:
jlentini on PROD1PC65 with NOTICES
Drug
Schedule
Methcathinone (1237) ..................
N–Ethylamphetamine (1475) ........
N,N–Dimethylamphetamine
(1480).
4–Methylaminorex (cis isomer)
(1590).
Alpha–Ethyltryptamine (7249) ......
Lysergic acid diethylamide (7315)
2,5–dimethoxy–4–(n)–
propylthiophenethylamine (2C–
T–7) (7348).
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
4–Bromo–2,5–
dimethoxyamphetamine (7391).
4–Bromo–2,5–
dimethoxyphenethylamine
(7392).
4–Methyl–2,5–
dimethoxyamphetamine (7395).
2,5–Dimethoxyamphetamine
(7396).
2,5–Dimethoxy–4–
ethylamphetamine (7399).
VerDate Aug<31>2005
19:31 Dec 21, 2006
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Jkt 211001
Drug
Schedule
3,4–Methylenedioxyamphetamine
(7400).
N–Hydroxy–3,4–
methylenedioxyamphetamine
(7402).
3,4–Methylenedioxy–N–
ethylamphetamine (7404).
3,4–
Methylenedioxymethamphetamine (7405).
4–Methoxyamphetamine (7411) ...
Alpha–methyltryptamine
(AMT)
(7432).
Bufotenine (7433) .........................
Diethyltryptamine (7434) ..............
Dimethyltryptamine (7435) ...........
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
5–methoxy–N–,N–
diisopropyltryptamine(5–MeO–
DIPT) (7439).
N–Ethyl–1–
phenylcyclohexylamine (7455).
1–(1–Phenylcyclohexyl)pyrrolidine
(PCPy) (7458).
1–[1–(2–
Thienyl)cyclohexyl]piperidine
(7470).
Dihydromorphine (9145) ...............
Normorphine (9313) .....................
Methamphetamine (1105) ............
1–Phenylcylohexylamine (7460) ..
Phencyclidine (7471) ....................
Phenylacetone (8501) ..................
1–Piperidinocyclohexanecarbonitrile (8603).
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Benzoylecgonine (9180) ...............
Ethylmorphine (9190) ...................
Meperidine intermediate–B (9233)
Morphine (9300) ...........................
Noroxymorphone (9668) ..............
I
I
I
I
Frm 00104
Fmt 4703
Sfmt 4703
Dated: December 14, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–21875 Filed 12–21–06; 8:45 am]
BILLING CODE 4410–09–P
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
high purity drug standards used for
analytical application only in clinical,
toxicological and forensic laboratories.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Applied Science Labs, Division of
Alltech Associates Inc. to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Applied Science Labs,
Division of Alltech Associates Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
PO 00000
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated August 15, 2006, and
published in the Federal Register on
August 22, 2006, (71 FR 48945–48946),
Cambrex North Brunswick, Inc.,
Technology Centre of New Jersey, 661
Highway One, North Brunswick, New
Jersey 08902, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
schedule I and II:
Drug
N-Ethylamphetamine (1475) ........
Tetrahydrocannabinols (7370) .....
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
4-Methoxyamphetamine (7411) ...
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Pentobarbital (2270) .....................
Phenylacetone (8501) ..................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Methadone (9250) ........................
Methadone Intermediate (9254) ...
Morphine (9300) ...........................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
Schedule
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Cambrex North Brunswick, Inc. to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Cambrex North Brunswick,
Inc. to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
E:\FR\FM\22DEN1.SGM
22DEN1
]]>Agencies
[Federal Register Volume 71, Number 246 (Friday, December 22, 2006)]
[Notices]
[Pages 77062-77063]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-21879]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances Notice of Registration
By Notice dated August 15, 2006, and published in the Federal
Register on August 22, 2006, (71 FR 48944-48945), American Radiolabeled
Chemicals, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made
application by renewal and by correspondence dated June 2, 2006, to the
Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed in
schedule I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Gamma hydroxybutyric acid (2010)........... I
Ibogaine (7260)............................ I
Lysergic acid diethylamide (7315).......... I
Tetrahydrocannabinols (7370)............... I
Dimethyltryptamine (7435).................. I
Dihydromorphine (9145)..................... I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Amobarbital (2125)......................... II
Phencyclidine (7471)....................... II
Phenylacetone (8501)....................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Ecgonine (9180)............................ II
Hydrocodone (9193)......................... II
Meperidine (9230).......................... II
Metazocine (9240).......................... II
Morphine (9300)............................ II
Thebaine (9333)............................ II
Oxymorphone (9652)......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances as radiolabeled compounds for biochemical
research.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
American Radiolabeled Chemicals, Inc. to manufacture the listed basic
classes of controlled substances is consistent
[[Page 77063]]
with the public interest at this time. DEA has investigated American
Radiolabeled Chemicals, Inc. to ensure that the company's registration
is consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above
named company is granted registration as a bulk manufacturer of the
basic classes of controlled substances listed.
Dated: December 14, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-21879 Filed 12-21-06; 8:45 am]
BILLING CODE 4410-09-P
